Document is current
Any future updates will be listed below
-
Authors
Brunelli, Cinzia
Borreani, Claudia
Caraceni, Augusto
Roli, Anna
Bellazzi, Marco
Lombi, Linda
Zito, Emanuela http://orcid.org/0000-0002-8318-4030
Pellegrini, Chiara
Spada, Pierangelo
Kaasa, Stein
Foschi, Anna Maria
Apolone, Giovanni
,
Apolone, Giovanni
Bellazzi, Marco
Belli, Filiberto
Borreani, Claudia
Brunelli, Cinzia
Capri, Giuseppe
Caraceni, Augusto
Casali, Paolo
Corradini, Paolo
de Braud, Filippo
Foschi, Anna Maria
Folli, Secondo
Garassino, Marina
Licitra, Lisa
Nicolai, Nicola
Pellegrini, Chiara
Platania, Marco
Procopio, Giuseppe
Roli, Anna
Salvioni, Roberto
Spada, Pierangelo
Valdagni, Riccardo
Zito, Emanuela
-
Funding
Funding for this research was provided by:
Ministero della Salute (5x1000 Funds – 2015 - ID code D171CB)
- License Information
-
More Information
Article History
Received: 9 January 2020
Accepted: 20 July 2020
First Online: 28 July 2020
Ethics approval and consent to participate
: The project protocol was registered on (Identifier: NCT03968718, URL: ) and approved by the Institutional review board (INT 167/18). Written informed consent to participate will be registered for all enrolled patients.
: Not applicable.
: Dr. Caraceni reports personal fees from Kyowa Kirin; Shionogi & Molteni; Angelini; Institute de recherche “Pierre Fabre”; Sandoz International GmbH; Italfarmaco; Pfizer; Molteni & soc. esercizio SpA; Helsin Healthcare; Gruenenthal GmbH, and grants from Molteni & C Soc Esercizio Spa; Prokstrakan; Gruenenthal GmbH; Amgen; Ipsen, outside the submitted work.All other authors declare that they have no competing interests.
